Literature DB >> 19714866

Protective protein/cathepsin A rescues N-glycosylation defects in neuraminidase-1.

Dongning Wang1, Slava Zaitsev, Garry Taylor, Alessandra d'Azzo, Erik Bonten.   

Abstract

BACKGROUND: Neuraminidase-1 (NEU1) catabolizes the hydrolysis of sialic acids from sialo-glycoconjugates. NEU1 depends on its interaction with the protective protein/cathepsin A (PPCA) for lysosomal compartmentalization and catalytic activation. Murine NEU1 contains 4 N-glycosylation sites, 3 of which are conserved in the human enzyme. The expression of NEU1 gives rise to differentially glycosylated proteins.
METHODS: We generated single-point mutations in mouse NEU1 at each of the 4 N-glycosylation sites. Mutant enzymes were expressed in NEU1-deficient cells in the presence and absence of PPCA.
RESULTS: All 4 N-glycosylation variants were targeted to the lysosomal/endosomal compartment. All N-glycans, with the exception of the most C-terminal glycan, were important for maintaining stability or catalytic activity. The loss of catalytic activity caused by the deletion of the second N-glycan was rescued by increasing PPCA expression. Similar results were obtained with a human NEU1 N-glycosylation mutant identified in a sialidosis patient. The N-terminal N-glycan of NEU1 is indispensable for its function, whereas the C-terminal N-glycan appears to be non-essential. The omission of the second N-glycan can be compensated for by upregulating the expression of PPCA. GENERAL SIGNIFICANCE: These findings could be relevant for the design of target therapies for patients carrying specific NEU1 mutations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19714866      PMCID: PMC2888680          DOI: 10.1016/j.bbagen.2009.01.006

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  28 in total

Review 1.  Comparative protein structure modeling of genes and genomes.

Authors:  M A Martí-Renom; A C Stuart; A Fiser; R Sánchez; F Melo; A Sali
Journal:  Annu Rev Biophys Biomol Struct       Date:  2000

2.  Linear programming optimization and a double statistical filter for protein threading protocols.

Authors:  J Meller; R Elber
Journal:  Proteins       Date:  2001-11-15

3.  Enriching the sequence substitution matrix by structural information.

Authors:  Octavian Teodorescu; Tamara Galor; Jaroslaw Pillardy; Ron Elber
Journal:  Proteins       Date:  2004-01-01

4.  Protein structure modeling with MODELLER.

Authors:  Narayanan Eswar; David Eramian; Ben Webb; Min-Yi Shen; Andrej Sali
Journal:  Methods Mol Biol       Date:  2008

5.  Lysosomal neuraminidase. Catalytic activation in insect cells is controlled by the protective protein/cathepsin A.

Authors:  E J Bonten; A d'Azzo
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

6.  Functional amelioration of murine galactosialidosis by genetically modified bone marrow hematopoietic progenitor cells.

Authors:  Thasia Leimig; Linda Mann; Maria del Pilar Martin; Erik Bonten; Derek Persons; James Knowles; James A Allay; John Cunningham; Arthur W Nienhuis; Richard Smeyne; Alessandra d'Azzo
Journal:  Blood       Date:  2002-05-01       Impact factor: 22.113

7.  Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice.

Authors:  Natalie de Geest; Erik Bonten; Linda Mann; Jean de Sousa-Hitzler; Christopher Hahn; Alessandra d'Azzo
Journal:  Hum Mol Genet       Date:  2002-06-01       Impact factor: 6.150

Review 8.  Molecular pathology of NEU1 gene in sialidosis.

Authors:  Volkan Seyrantepe; Helena Poupetova; Roseline Froissart; Marie-Thérèse Zabot; Irène Maire; Alexey V Pshezhetsky
Journal:  Hum Mutat       Date:  2003-11       Impact factor: 4.878

9.  N-linked glycosylation sites of the motor protein prestin: effects on membrane targeting and electrophysiological function.

Authors:  Keiji Matsuda; Jing Zheng; Guo-Guang Du; Nikolaj Klöcker; Laird D Madison; Peter Dallos
Journal:  J Neurochem       Date:  2004-05       Impact factor: 5.372

10.  Deglycosylation, processing and crystallization of human testis angiotensin-converting enzyme.

Authors:  Kerry Gordon; Pierre Redelinghuys; Sylva L U Schwager; Mario R W Ehlers; Anastassios C Papageorgiou; Ramanathan Natesh; K Ravi Acharya; Edward D Sturrock
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

View more
  6 in total

1.  Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.

Authors:  Trisha M Finlay; Preethi Jayanth; Schammim Ray Amith; Alanna Gilmour; Christina Guzzo; Katrina Gee; Rudi Beyaert; Myron R Szewczuk
Journal:  Glycoconj J       Date:  2010-03-06       Impact factor: 2.916

2.  Heterodimerization of the sialidase NEU1 with the chaperone protective protein/cathepsin A prevents its premature oligomerization.

Authors:  Erik J Bonten; Yvan Campos; Viateslav Zaitsev; Amanda Nourse; Brett Waddell; William Lewis; Garry Taylor; Alessandra d'Azzo
Journal:  J Biol Chem       Date:  2009-08-07       Impact factor: 5.157

3.  Chaperone-mediated gene therapy with recombinant AAV-PPCA in a new mouse model of type I sialidosis.

Authors:  Erik J Bonten; Gouri Yogalingam; Huimin Hu; Elida Gomero; Diantha van de Vlekkert; Alessandra d'Azzo
Journal:  Biochim Biophys Acta       Date:  2013-06-12

4.  In silico identification of new putative pathogenic variants in the NEU1 sialidase gene affecting enzyme function and subcellular localization.

Authors:  Dario Bonardi; Viola Ravasio; Giuseppe Borsani; Alessandra d'Azzo; Roberto Bresciani; Eugenio Monti; Edoardo Giacopuzzi
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

5.  Using Bibliometric Analysis and Machine Learning to Identify Compounds Binding to Sialidase-1.

Authors:  Jennifer J Klein; Nancy C Baker; Daniel H Foil; Kimberley M Zorn; Fabio Urbina; Ana C Puhl; Sean Ekins
Journal:  ACS Omega       Date:  2021-01-20

6.  Novel mutations in the neuraminidase-1 (NEU1) gene in two patients of sialidosis in India.

Authors:  Prajnya Ranganath; Vishakha Sharma; Sumita Danda; Madhusudan R Nandineni; Ashwin B Dalal
Journal:  Indian J Med Res       Date:  2012-12       Impact factor: 2.375

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.